National Health (Immunisation Program – Designated Vaccines) Variation Determination (No. 2) 2018 (Cth)

National Health (Immunisation Program – Designated Vaccines) Variation Determination (No. 2) 2018

National Health Act 1953

I, Masha Somi, delegate of the Minister for Health, make this Determination under subsection 9B(2) of the National Health Act 1953.

Dated 30 May 2018

Dr Masha Somi

Immunisation Branch

Office of Health Protection

Chief Medical Officer Group

Department of Health

1. Name of Determination

This Determination is the National Health (Immunisation Program – Designated Vaccines) Variation Determination (No. 2) 2018.

1. Commencement

This Determination commences on the day after registration.

3       Authority

This Determination is made under subsection 9B(2) of the National Health Act 1953.          

1. Variation of National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No. 1)

Schedule 1 varies the National Health (Immunisation Program – Designated     Vaccines) Determination 2014 (No. 1).

Schedule 1           Amendments

[1] Subsection 7(1)

Repeal the subsection, substitute:

1. For item 110 of Schedule 1, a designated vaccine in that item may be provided in the following circumstances:

(a)        a dose of the vaccine may be provided to a child:

(i) who is an Aboriginal and/or Torres Strait Islander; and

(ii) who is about 12 months; and

(iii) who lives in Queensland, Western Australia, South Australia or the Northern Territory;

[2] Item 103 in Schedule 1, Part 1

Omit “Haemophilus influenza”, substitute “Haemophilus influenzae”.

[3] Item 110 in Schedule 1, Part 1

Repeal the item, substitute:

110 Vaccine Pneumococcal (conjugate, 13 valent) Circumstances Vaccine may be provided: (a)     to a child who is:                  i.       about 2 months old, and                 ii.      about 4 months old; and                iii.      at least 12 months old but less than 24 months old; and (b)   to a child who is about 6 months of age and is a member of a medical risk group; or (c)    Vaccine may be provided in the circumstances set out in subsection 7 (1) Prevenar 13 Injection (0.5mL) Polysaccharides of Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 9V, 14, 18C, 19A, 19F, 23F - 2.2 µg of each of serotype, and 4.4 μg of serotype 6B 2 or 3 doses of a primary course plus a booster dose or a single supplementary dose

[4] Item 207D in Schedule 1, Part 1

Omit “Vaccine may be provided may be provided to a person who is at least 65 years of age”, substitute “Vaccine may be provided to a person who is at least 65 years of age”.

[5] Item 207E in Schedule 1, Part 1

Omit “Vaccine may be provided may be provided to a person who is at least 65 years of age”, substitute “Vaccine may be provided to a person who is at least 65 years of age”.